Trials / Recruiting
RecruitingNCT05129969
Registry Platform Ovarian and Endometrial Cancer
SMARAGD - Clinical Research Platform on Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancer Treatment and Outcomes
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,975 (estimated)
- Sponsor
- iOMEDICO AG · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced or metastatic ovarian cancer (OC) or advanced or metastatic endometrial cancer (EC) in Germany.
Detailed description
SMARAGD is a national, prospective, open-label, longitudinal, non-interventional multicenter cohort study (tumour registry platform) to describe treatment in routine clinical practice of ovarian, fallopian tube, primary peritoneal and endometrial patients in routine care in Germany. The registry will follow patients for up to three years with the aim to identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Health-related quality of life (HRQoL) will be evaluated for up to three years.
Conditions
- Ovarian Cancer
- Endometrial Cancer
- Ovary Neoplasm
- Endometrial Neoplasms
- Carcinoma, Ovarian
- Carcinoma
- Neoplasm, Ovarian
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Physician's choice according to patient's needs. | Routine care as per site standard. |
Timeline
- Start date
- 2021-11-25
- Primary completion
- 2030-12-01
- Completion
- 2030-12-01
- First posted
- 2021-11-22
- Last updated
- 2026-01-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05129969. Inclusion in this directory is not an endorsement.